Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders

NCT00006056 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chediak-Higashi Syndrome
Graft Versus Host Disease
X-Linked Lymphoproliferative Syndrome
Familial Erythrophagocytic Lymphohistiocytosis
Hemophagocytic Lymphohistiocytosis
Virus-Associated Hemophagocytic Syndrome

Interventions

DRUG: anti-thymocyte globulin
DRUG: busulfan
DRUG: cyclophosphamide
DRUG: cyclosporine
DRUG: etoposide
DRUG: filgrastim
DRUG: methotrexate
PROCEDURE: allogeneic hematopoietic stem cell transplantation

Sponsor

Fairview University Medical Center